These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
These kits are intended for in vitro diagnostic use.
These kits are for research use only and are not intended to be used for diagnostic procedures.
Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
Biological risk products.
Storage between 2 and 8 ° C.
Reactive in liquid form.
Reactive in lyophilized form.
Reactive in frozen form.
Stability after opening at 2-8 ° C.
Products that can be refrozen.
Stability 12 months after refreezing at -20 ° C.
Antigen: Beta chain of fibrinogen / human fibrin (57 kDa)
Application : IHC Host : Mouse
The Safety Data Sheets and Notices are accessible to our registered customers.
The cleavage of fibrinogen to fibrin by thrombin is the final event of the coagulation cascade. Fibrinogen is an M40 kDa glycoprotein synthesized by the liver. Thrombin cleaves the NH2 end of the Aa chain releasing fibrinopeptide A and generating fibrin. Thrombin also cleaves the NH2 end of the Bb chain releasing fibrinopeptide B. Fibrinopeptides allow the Aa and Bb chains to polymerize and form the fibrin network.
The lyophilized presentation allows greater stability until the expiration date.